NCT06652750 Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
| NCT ID | NCT06652750 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Third People's Hospital of Chengdu |
| Condition | Sick Sinus Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 688 participants |
| Start Date | 2024-11-13 |
| Primary Completion | 2025-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 688 participants in total. It began in 2024-11-13 with a primary completion date of 2025-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objective: This clinical study employs a prospective, paired, self-controlled, non-inferiority, multicenter research design to assess the safety and efficacy of utilizing 5G cloud follow-up for CIED in parameters monitoring and remote programming post-implantation. Participants will: undergo regular clinic follow-up visits in accordance with the guidelines undergo routine in-office follow-up and 5G cloud follow-up during each regular clinic visit
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years, gender unspecified; 2. Patients who have not undergone their first clinic follow-up after the implantation of cardiovascular implantable electronic devices (CIED); Note: In this study, CIED includes pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy pacemakers (CRT-P) and defibrillators (CRT-D), excluding implantable cardiac event recorders (ICM) and implantable cardiovascular monitors. 3. Willing to participate in this clinical study and have signed the informed consent form in writing. Exclusion Criteria: * Exclusion Criteria: If meeting any of the following, the individual cannot be included: 1. Life expectancy \< 1 year. 2. Inability to cooperate with treatment or follow-up, such as having mental illness. 3. Participated in other clinical studies within 30 days before enrollment. Other situations that the researcher deems unsuitable for inclusion.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06652750 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sick Sinus Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06652750 currently recruiting?
Yes, NCT06652750 is actively recruiting participants. Contact the research team at clin63@yeah.net for enrollment information.
Where is the NCT06652750 trial being conducted?
This trial is being conducted at Guangzhou, China, Chengdu, China.
Who is sponsoring the NCT06652750 clinical trial?
NCT06652750 is sponsored by The Third People's Hospital of Chengdu. The trial plans to enroll 688 participants.